Core Concepts
Hypertension prevalence in the US remained stable at 30% post-2017 guidelines, with a 3% rise in antihypertensive medication use.
Abstract
TOPLINE:
Hypertension prevalence stable at 30% in the US.
Antihypertensive medication use increased by 3%.
METHODOLOGY:
Data from the Behavioral Risk Factor Surveillance System analyzed.
Defined hypertension and treatment criteria.
Assessed by various demographics.
TAKEAWAY:
Analyzed samples from 2017, 2019, and 2021.
Hypertension prevalence remained at 30%.
Antihypertensive medication use increased by 3.1%.
Medication use varied across demographics and states.
IN PRACTICE:
Findings can aid in hypertension awareness and management.
SOURCE:
Study led by Ahlia Sekkarie, PhD, published in MMWR.
LIMITATIONS:
Based on self-report data.
Low response rates may affect estimates.
Exclusions of certain populations and small sample sizes noted.
DISCLOSURES:
No specific funding reported, no conflicts of interest.
Stats
Hypertension prevalence in the US remained stable at 30%.
Antihypertensive medication use among individuals with hypertension increased by 3.1 percentage points.
Prevalence of medication use was higher among women than men (68.5% vs 59.4%).
Among adults aged ≥ 65 years, medication use was 92.5% compared to 42.5% in those aged 18-44 years.
Black patients had a higher prevalence of medication use compared to White patients (71.3% vs 62%).